Background When screening for macroprolactin, many laboratories use precipitation by polyethylene glycol (PEG) with molecular weight 6000 (PEG6000) or 8000 (PEG8000), and report the percentage prolactin recovery. It has been proposed that reporting of percentage prolactin recovery should be replaced by absolute post-PEG prolactin; however, the post-PEG prolactin reference interval has been established using PEG6000 only. We sought to determine whether the use of PEG8000, instead of PEG6000, changed post-PEG prolactin concentrations. Methods We compared the post-PEG6000 and post-PEG8000 prolactin concentrations in hyperprolactinaemic serum samples referred for macroprolactin screening (n = 40), using Passing–Bablok regression analysis and Bland–Altman difference plot. Results The median (25th–75th percentile, range) total prolactin, post-PEG6000 and post-PEG8000 prolactin concentrations were, respectively, 36 (31–46, 23–83) μg/L, 27 (20–38, 18–72) μg/L and 24 (18–35, 16–64) μg/L for male serum samples (n = 5); and 56 (39–83, 24–596) μg/L, 45 (31–67, 8–503) μg/L and 41 (28–62, 6–457) μg/L for female serum samples (n = 35) (mIU/L conversion factor: 21.2). The Passing–Bablok analysis demonstrated a significant constant bias of −1.27 and a non-significant proportional bias of 0.96. The Bland–Altman plot showed a bias of −8.2% (95% limits of agreement −19.3–2.9%). Conclusions There is a significant constant bias between the two macroprolactin precipitation methods. We changed our PEG precipitation to a PEG6000 method. Laboratories that use PEG8000 should consider the transference of the reference interval established with PEG6000 carefully.
[1]
Thomas P. Smith,et al.
Reporting of post-PEG prolactin concentrations: time to change.
,
2010,
Clinical chemistry.
[2]
Thomas P. Smith,et al.
Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients
,
2009,
Clinical endocrinology.
[3]
Thomas P. Smith,et al.
Serum total prolactin and monomeric prolactin reference intervals determined by precipitation with polyethylene glycol: evaluation and validation on common immunoassay platforms.
,
2008,
Clinical chemistry.
[4]
J. Gibney,et al.
Specificity and clinical utility of methods for the detection of macroprolactin.
,
2004,
Clinical chemistry.
[5]
R. John,et al.
Macroprolactin; high molecular mass forms of circulating prolactin
,
2005,
Annals of clinical biochemistry.
[6]
J. Gibney,et al.
Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia.
,
2003,
Clinical chemistry.